FDA Import Refusal AEK-1364915-5/31/1 — GLAXOSMITHKLINE PHARMACEUTICALS
The FDA refused shipment AEK-1364915-5/31/1 from GLAXOSMITHKLINE PHARMACEUTICALS (India) on Jul 26, 2022. The refused product falls under Drugs and Biologics — DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 26, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GCY90 DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY)
- Charges
- 75